CAR--话题@MedSci - williamhill asia

#CAR-#

459篇内容 | 3311人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1781519, encodeId=50731e81519bc, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Blood：全基因组测序揭示CAR-19 T细胞治疗淋巴瘤失败的潜在复杂基因组特征, objectType=article, longId=736188, objectId=5ba0e36188df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ba0e36188df, replyNumber=0, likeNumber=90, createdTime=2023-03-21, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ba0e36188df, moduleTitle=Blood：全基因组测序揭示CAR-19 T细胞治疗淋巴瘤失败的潜在复杂基因组特征, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=5ba0e36188df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781516, encodeId=21a21e81516a7, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T细胞生产工艺中的关键环节有哪些？如何规模化、安全稳定的生产制备？, objectType=article, longId=735144, objectId=4b13e3514457, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b13e3514457, replyNumber=0, likeNumber=109, createdTime=2023-01-16, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b13e3514457, moduleTitle=CAR-T细胞生产工艺中的关键环节有哪些？如何规模化、安全稳定的生产制备？, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=4b13e3514457)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781527, encodeId=e7821e815274d, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Nat Med：CAR-T细胞疗法新突破：成功治疗多个红斑狼疮患者，并实现长期无药物缓解, objectType=article, longId=739821, objectId=9710e3982159, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9710e3982159, replyNumber=0, likeNumber=97, createdTime=2022-10-07, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9710e3982159, moduleTitle=Nat Med：CAR-T细胞疗法新突破：成功治疗多个红斑狼疮患者，并实现长期无药物缓解, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=9710e3982159)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781520, encodeId=c5b51e815207e, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=《Cell Discovery》浙江大学应颂敏/沈华浩团队开发CCAR-T治疗哮喘新手段, objectType=article, longId=736218, objectId=de49e36218e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=de49e36218e1, replyNumber=0, likeNumber=118, createdTime=2023-07-18, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de49e36218e1, moduleTitle=《Cell Discovery》浙江大学应颂敏/沈华浩团队开发CCAR-T治疗哮喘新手段, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=de49e36218e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781524, encodeId=30681e8152441, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Nat Biotech：一次生产10亿CAR-T细胞，新型CRISPR技术，无需病毒载体高效插入超长DNA序列, objectType=article, longId=739036, objectId=f1d8e3903613, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1d8e3903613, replyNumber=0, likeNumber=74, createdTime=2022-12-06, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1d8e3903613, moduleTitle=Nat Biotech：一次生产10亿CAR-T细胞，新型CRISPR技术，无需病毒载体高效插入超长DNA序列, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=f1d8e3903613)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781487, encodeId=eb921e814872a, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=突破CAR-T细胞治疗实体瘤瓶颈--《自然-医学》杂志发表沈琳教授团队研究成果, objectType=article, longId=726575, objectId=1577e2657557, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1577e2657557, replyNumber=0, likeNumber=89, createdTime=2022-10-22, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1577e2657557, moduleTitle=突破CAR-T细胞治疗实体瘤瓶颈--《自然-医学》杂志发表沈琳教授团队研究成果, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=1577e2657557)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781498, encodeId=67611e8149815, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Nature：池洪波/郭傲/黄宏龄等揭示改善实体瘤CAR-T疗效的新方法, objectType=article, longId=730561, objectId=953ee305613e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=953ee305613e, replyNumber=0, likeNumber=92, createdTime=2023-01-07, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=953ee305613e, moduleTitle=Nature：池洪波/郭傲/黄宏龄等揭示改善实体瘤CAR-T疗效的新方法, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=953ee305613e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781502, encodeId=f5021e8150277, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=传奇生物第二款出海CAR-T LB1901，在美国临床试验终止, objectType=article, longId=731954, objectId=1978e31954ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1978e31954ca, replyNumber=0, likeNumber=84, createdTime=2023-04-28, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1978e31954ca, moduleTitle=传奇生物第二款出海CAR-T LB1901，在美国临床试验终止, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=1978e31954ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781501, encodeId=06071e8150158, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=CAR-T之父最新Nature论文！无需放化疗，新型T细胞疗法成功治愈超半数难治型实体瘤小鼠, objectType=article, longId=731697, objectId=1fbce3169782, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1fbce3169782, replyNumber=0, likeNumber=81, createdTime=2022-11-13, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1fbce3169782, moduleTitle=CAR-T之父最新Nature论文！无需放化疗，新型T细胞疗法成功治愈超半数难治型实体瘤小鼠, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=1fbce3169782)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781525, encodeId=a7401e81525c5, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=ESMO 2022：CAR-T治疗用于实体瘤研究发布多项重要研究成果！, objectType=article, longId=739081, objectId=ec8be39081d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec8be39081d7, replyNumber=0, likeNumber=71, createdTime=2023-03-09, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec8be39081d7, moduleTitle=ESMO 2022：CAR-T治疗用于实体瘤研究发布多项重要研究成果！, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=ec8be39081d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781488, encodeId=05c31e81488b6, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=第二代CAR-iMac，浙江大学张进团队在CAR-巨噬细胞领域取得系列进展, objectType=article, longId=726718, objectId=d18be2671804, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d18be2671804, replyNumber=0, likeNumber=89, createdTime=2022-12-02, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d18be2671804, moduleTitle=第二代CAR-iMac，浙江大学张进团队在CAR-巨噬细胞领域取得系列进展, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=d18be2671804)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781491, encodeId=1e2e1e8149190, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Cancer Discov：阻断TIGIT有望改善靶向CD19的CAR-T细胞疗法对非霍奇金淋巴瘤的疗效, objectType=article, longId=728112, objectId=d043e28112d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d043e28112d0, replyNumber=0, likeNumber=70, createdTime=2023-01-23, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d043e28112d0, moduleTitle=Cancer Discov：阻断TIGIT有望改善靶向CD19的CAR-T细胞疗法对非霍奇金淋巴瘤的疗效, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=d043e28112d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781496, encodeId=fb971e8149626, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Science Advances：单细胞分析揭示靶向CD19的CAR-T疗法复发的机制, objectType=article, longId=729835, objectId=92c6e29835d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=92c6e29835d2, replyNumber=0, likeNumber=108, createdTime=2022-08-19, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=92c6e29835d2, moduleTitle=Science Advances：单细胞分析揭示靶向CD19的CAR-T疗法复发的机制, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=92c6e29835d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781523, encodeId=fc401e81523c0, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=盘点全球已上市的8种CAR-T细胞治疗, objectType=article, longId=739000, objectId=464be390009f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=464be390009f, replyNumber=0, likeNumber=84, createdTime=2023-06-17, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=464be390009f, moduleTitle=盘点全球已上市的8种CAR-T细胞治疗, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=464be390009f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781490, encodeId=56f71e814903a, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=通用型CAR-T细胞CB-010治疗复发/难治性B细胞非霍奇金淋巴瘤，初步结果达到100%ORR和80%CR, objectType=article, longId=726862, objectId=923fe2686288, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=923fe2686288, replyNumber=0, likeNumber=82, createdTime=2023-03-11, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=923fe2686288, moduleTitle=通用型CAR-T细胞CB-010治疗复发/难治性B细胞非霍奇金淋巴瘤，初步结果达到100%ORR和80%CR, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=923fe2686288)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781514, encodeId=90921e8151496, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=【Blood Adv】rrDLBCL患者的基因突变谱及对CAR-T治疗的疗效, objectType=article, longId=734616, objectId=122ee346162f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=122ee346162f, replyNumber=0, likeNumber=70, createdTime=2023-06-29, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=122ee346162f, moduleTitle=【Blood Adv】rrDLBCL患者的基因突变谱及对CAR-T治疗的疗效, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=122ee346162f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781526, encodeId=12f81e8152602, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=BioNTech的mRNA疫苗联合CAR-T治疗实体瘤临床效果下降，但对睾丸癌效果亮眼, objectType=article, longId=739304, objectId=992ee39304e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=992ee39304e3, replyNumber=0, likeNumber=121, createdTime=2023-02-21, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=992ee39304e3, moduleTitle=BioNTech的mRNA疫苗联合CAR-T治疗实体瘤临床效果下降，但对睾丸癌效果亮眼, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=992ee39304e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781477, encodeId=bfef1e8147723, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=Science Advances：通过水凝胶递送CAR-T细胞，改善实体瘤治疗效果, objectType=article, longId=723978, objectId=a1f2e2397886, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1f2e2397886, replyNumber=0, likeNumber=76, createdTime=2022-07-17, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1f2e2397886, moduleTitle=Science Advances：通过水凝胶递送CAR-T细胞，改善实体瘤治疗效果, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=a1f2e2397886)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781473, encodeId=d6a51e81473e9, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=欧盟CHMP为两款CAR-T疗法Carvykti和Kymriah大开绿灯, objectType=article, longId=301794, objectId=e0bb301e9432, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0bb301e9432, replyNumber=0, likeNumber=76, createdTime=2022-03-31, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0bb301e9432, moduleTitle=欧盟CHMP为两款CAR-T疗法Carvykti和Kymriah大开绿灯, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=e0bb301e9432)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1781522, encodeId=c0571e8152299, content=<a href='/topic/show?id=8ce8405907' target=_blank style='color:#2F92EE;'>#CAR-#</a>, objectTitle=浅谈T细胞分选在CAR-T细胞制备中的应用及未来发展趋势, objectType=article, longId=738247, objectId=e208e3824788, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e208e3824788, replyNumber=0, likeNumber=80, createdTime=2022-11-16, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e208e3824788, moduleTitle=浅谈T细胞分选在CAR-T细胞制备中的应用及未来发展趋势, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=e208e3824788)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] williamhill asia 话题小助手

CAR-

2020-05-29

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Blood：全基因组测序揭示CAR-19 T细胞治疗淋巴瘤失败的潜在复杂基因组特征

2023-03-21

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T细胞生产工艺中的关键环节有哪些？如何规模化、安全稳定的生产制备？

2023-01-16

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Nat Med：CAR-T细胞疗法新突破：成功治疗多个红斑狼疮患者，并实现长期无药物缓解

2022-10-07

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

《Cell Discovery》浙江大学应颂敏/沈华浩团队开发CCAR-T治疗哮喘新手段

2023-07-18

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Nat Biotech：一次生产10亿CAR-T细胞，新型CRISPR技术，无需病毒载体高效插入超长DNA序列

2022-12-06

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

突破CAR-T细胞治疗实体瘤瓶颈--《自然-医学》杂志发表沈琳教授团队研究成果

2022-10-22

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Nature：池洪波/郭傲/黄宏龄等揭示改善实体瘤CAR-T疗效的新方法

2023-01-07

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

传奇生物第二款出海CAR-T LB1901，在美国临床试验终止

2023-04-28

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

CAR-T之父最新Nature论文！无需放化疗，新型T细胞疗法成功治愈超半数难治型实体瘤小鼠

2022-11-13

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

ESMO 2022：CAR-T治疗用于实体瘤研究发布多项重要研究成果！

2023-03-09

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

第二代CAR-iMac，浙江大学张进团队在CAR-巨噬细胞领域取得系列进展

2022-12-02

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Cancer Discov：阻断TIGIT有望改善靶向CD19的CAR-T细胞疗法对非霍奇金淋巴瘤的疗效

2023-01-23

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Science Advances：单细胞分析揭示靶向CD19的CAR-T疗法复发的机制

2022-08-19

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

盘点全球已上市的8种CAR-T细胞治疗

2023-06-17

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

通用型CAR-T细胞CB-010治疗复发/难治性B细胞非霍奇金淋巴瘤，初步结果达到100%ORR和80%CR

2023-03-11

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

【Blood Adv】rrDLBCL患者的基因突变谱及对CAR-T治疗的疗效

2023-06-29

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

BioNTech的mRNA疫苗联合CAR-T治疗实体瘤临床效果下降，但对睾丸癌效果亮眼

2023-02-21

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

Science Advances：通过水凝胶递送CAR-T细胞，改善实体瘤治疗效果

2022-07-17

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

欧盟CHMP为两款CAR-T疗法Carvykti和Kymriah大开绿灯

2022-03-31

仁者大医 (审核中...)

前往app查看评论内容

#CAR-#

浅谈T细胞分选在CAR-T细胞制备中的应用及未来发展趋势

2022-11-16

科室
- - 订阅+
  - 更多科室
工具
服务